Prof. Matt Cooper

Antibiotic Octapeptin – forgotten, but offers now hope against superbugs!

Octapeptin was discovered in the late 1970s but were not selected for development at the time. Now researchers synthesized the antibiotic. In the occasion of the recently published study we interviewed Prof. Matt Cooper, Director of the IMB’s Centre for Superbug Solutions. In the face of increasing antimicrobial resistance it has become clear that new […]

Kill bacteria with bacteria: Promising approach that could help combat antibiotic resistance?

A team of researchers, funded by the Defense Advanced Research Projects Agency (DARPA) tries to find out whether an unusual type of bacteria that eats other bacteria could be a new weapon in the fight against drug-resistant infections (investigated in the course of the Pathogen Predators Program). We interviewed Prof. Liz Sockett from the Nottingham […]

What our work suggests is that people who are susceptible to CDI may be well advised to avoid consumption of trehalose

The increased use of the disaccharide trehalose could have promoted the spread of the virulent Clostridium difficile (CD) strains RT027 and RT078. This has shown a recently published study. An interview with study author Dr James Collins (Baylor College of Medicine, Department of Molecular Virology and Microbiology, Houston, Texas) Mr. Collins, What gave you the […]

We slowly learn that if we want to get out of the vicious circle, there is no other way but to act!

In two weeks we are celebrating the World Antibiotic Awareness Week (13-19 Nov.). On the occasion of this event we made some interviews with representatives of CEE-countries (where antibiotic misuse is still a big issue). Read our first interview with Dr Andreea Moldovan (St. Constantin Hospital Romania). Andreea, do you celebrate the Antibiotic Awareness Week […]

EU countries should better uniform AMR monitoring in livestock and link them better to surveillance systems in humans

Comparing AMR surveillance programs from livestock and human health in Europe. That was the objective of a recently published review. We interviewed author Dr Remco Schrijver. One of the tables of the review (table 3) shows that no information could be retrieved from Bulgaria, Croatia, Latvia, Romania and Slovakia (reporting of national antimicrobial testing in […]

First Antimicrobial Resistance Benchmark – How will it work?

In August, the Access to Medicine Foundation published a methodology for the first Antimicrobial Resistance Benchmark. This is the first independently developed framework for analysing how the pharmaceutical industry can limit AMR. We interviewed Jayasree K. Iyer (Executive Director) about how the Benchmark will work and what expects her team to find out. First of […]

Dr. Chris Knight

AMR is rising rather in „lonely“ bacteria

Lonely bacteria are nearly ten times as likely to mutate to resist antibiotics as those living in dense populations – this is the topic of a recently published study in the PLOS journal. We interviewed the senior author of the study, Dr Chris Knight from the University of Manchester. It is very interesting to read […]

Dr. Enrique Castro-Sánchez

AMR: an interdisciplinary project, including design and visualisation to imagine the implications of antibiotic loss

Antimicrobial Resistance research projects have different faces. We want to present an exceptional one, that includes design and visualisation. An interview with Dr. Enrique Castro-Sánchez, Academic Research Nurse at the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance…. Using various approaches including design and visualisation to imagine the implications of antibiotic […]

SPARK – toward a Shared Platform for Antibiotic Research and Knowledge

To stimulate the development of innovative antibiotics in the battle against drug-resistant bacteria, the Pew Charitable Trusts announced that it will create a digital platform (SPARK = Shared Platform for Antibiotic Research and Knowledge). This platform allows researchers to share data, ideas and insights. An interview with Kathy Talkington, director of Pew’s antibiotic-resistance project. I […]

Prof. Céline Pulcini

Antibiotic Stewardship Teams: Two main actions are required!

Despite the importance of AS teams in optimizing the management of infections, they remain understaffed or non-existent in most countries. Two main actions are required, says Prof. Céline Pulcini (Université de Lorraine), author of a recently published Expert Commentary: First, staffing standards, based on the list of core actions that stewardship teams must implement. Second, […]